Support: +91-22-61011756 / help@projectstoday.com

Help

1. Boolean Searches :

i. AND - Shows results where both terms on either side of the 'AND' operator are present. 'AND' must be in upper case. For example search term - delhi AND metro result - It will return records in which 'delhi' as well as 'metro' both are present.

ii. OR - Shows results where either term (or both terms) is present. 'OR' must be in upper case. For example search term - delhi OR metro result - It will return records in which either 'delhi' or 'metro' or both are present

2. Proximity Searches

A proximity search looks for terms that are within a specific distance from one another. For example, search term - 'delhi metro'~10 result - It will search for records where 'delhi' and 'metro' are found within 10 words of each other

3. Phrase searches

You can search phrases using double quotes. for e.g. 'delhi metro' result - It will return records where 'delhi metro' phrase is found.

Projects Today - Trial Access

Increase your Business Opportunities

Free Trial See Sample Project

Bayer (South-East Asia) and Cadila Healthcare extend joint venture

Monday, 21 Jun 2021

Share this on :

Bayer (South-East Asia) and Cadila Healthcare have announced the extension of their joint venture (JV) by three years from June 2021.

The companies first entered into an agreement on 28 January 2011 to set up the JV-- Bayer Zydus Pharma for the sales and marketing of pharmaceutical products in India, with headquarters in Mumbai, Maharashtra.

Over the last 10 years, Bayer Zydus Pharma has been a successful partnership combining Bayer’s scientific expertise and commercialisation of novel products backed by Cadila Healthcare’s strong India presence.

The JV company focused on addressing the unmet healthcare needs of patients in India by providing best-in-class innovative health solutions.

During the term of the joint venture, the company also launched some of Bayer’s global innovative assets like Xarelto, EyleaTM and Visanne in India.

Bayer Zydus Pharma will continue to operate in core therapies including cardiovascular diseases, diabetes, women’s health, ophthalmology and oncology, with new products in the pipeline.

Key products in the company’s pharmaceutical portfolio include Xarelto, Glucobay, EyleaTM, Yaz, Mirena and Visanne, amongst others. Through strategic and time-honoured alliances with local partners, Bayer Zydus Pharma will continue to offer new-generation therapies to address the nation’s prevailing and emerging health concerns.